61 related articles for article (PubMed ID: 11160619)
1. Antimitotic actions of a novel analog of the fungal metabolite palmarumycin CP1.
Lazo JS; Tamura K; Vogt A; Jung JK; Rodriguez S; Balachandran R; Day BW; Wipf P
J Pharmacol Exp Ther; 2001 Feb; 296(2):364-71. PubMed ID: 11160619
[TBL] [Abstract][Full Text] [Related]
2. Tubulin-perturbing naphthoquinone spiroketals.
Balachandran R; Hopkins TD; Thomas CA; Wipf P; Day BW
Chem Biol Drug Des; 2008 Feb; 71(2):117-24. PubMed ID: 18194192
[TBL] [Abstract][Full Text] [Related]
3. A-204197, a new tubulin-binding agent with antimitotic activity in tumor cell lines resistant to known microtubule inhibitors.
Tahir SK; Han EK; Credo B; Jae HS; Pietenpol JA; Scatena CD; Wu-Wong JR; Frost D; Sham H; Rosenberg SH; Ng SC
Cancer Res; 2001 Jul; 61(14):5480-5. PubMed ID: 11454695
[TBL] [Abstract][Full Text] [Related]
4. BPR0L075, a novel synthetic indole compound with antimitotic activity in human cancer cells, exerts effective antitumoral activity in vivo.
Kuo CC; Hsieh HP; Pan WY; Chen CP; Liou JP; Lee SJ; Chang YL; Chen LT; Chen CT; Chang JY
Cancer Res; 2004 Jul; 64(13):4621-8. PubMed ID: 15231674
[TBL] [Abstract][Full Text] [Related]
5. Dual G1 and G2 phase inhibition by a novel, selective Cdc25 inhibitor 6-chloro-7-[corrected](2-morpholin-4-ylethylamino)-quinoline-5,8-dione.
Pu L; Amoscato AA; Bier ME; Lazo JS
J Biol Chem; 2002 Dec; 277(49):46877-85. PubMed ID: 12356752
[TBL] [Abstract][Full Text] [Related]
6. Apigenin inhibits growth and induces G2/M arrest by modulating cyclin-CDK regulators and ERK MAP kinase activation in breast carcinoma cells.
Yin F; Giuliano AE; Law RE; Van Herle AJ
Anticancer Res; 2001; 21(1A):413-20. PubMed ID: 11299771
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity analysis of the interaction of curacin A, the potent colchicine site antimitotic agent, with tubulin and effects of analogs on the growth of MCF-7 breast cancer cells.
Verdier-Pinard P; Lai JY; Yoo HD; Yu J; Marquez B; Nagle DG; Nambu M; White JD; Falck JR; Gerwick WH; Day BW; Hamel E
Mol Pharmacol; 1998 Jan; 53(1):62-76. PubMed ID: 9443933
[TBL] [Abstract][Full Text] [Related]
8. Salvinal, a novel microtubule inhibitor isolated from Salvia miltiorrhizae Bunge (Danshen), with antimitotic activity in multidrug-sensitive and -resistant human tumor cells.
Chang JY; Chang CY; Kuo CC; Chen LT; Wein YS; Kuo YH
Mol Pharmacol; 2004 Jan; 65(1):77-84. PubMed ID: 14722239
[TBL] [Abstract][Full Text] [Related]
9. Double blockade of cell cycle at g(1)-s transition and m phase by 3-iodoacetamido benzoyl ethyl ester, a new type of tubulin ligand.
Jiang JD; Denner L; Ling YH; Li JN; Davis A; Wang Y; Li Y; Roboz J; Wang LG; Perez-Soler R; Marcelli M; Bekesi G; Holland JF
Cancer Res; 2002 Nov; 62(21):6080-8. PubMed ID: 12414632
[TBL] [Abstract][Full Text] [Related]
10. Monensin-mediated growth inhibition in NCI-H929 myeloma cells via cell cycle arrest and apoptosis.
Park WH; Kim ES; Kim BK; Lee YY
Int J Oncol; 2003 Jul; 23(1):197-204. PubMed ID: 12792794
[TBL] [Abstract][Full Text] [Related]
11. Molecular characterization of oncostatin M-induced growth arrest of MCF-7 cells expressing a temperature-sensitive mutant of p53.
Li C; Shridhar K; Liu J
Breast Cancer Res Treat; 2003 Jul; 80(1):23-37. PubMed ID: 12889596
[TBL] [Abstract][Full Text] [Related]
12. Antitumor imidazolyl disulfide IV-2 causes irreversible G(2)/M cell cycle arrest without hyperphosphorylation of cyclin-dependent kinase Cdk1.
Vogt A; Tamura K; Watson S; Lazo JS
J Pharmacol Exp Ther; 2000 Sep; 294(3):1070-5. PubMed ID: 10945861
[TBL] [Abstract][Full Text] [Related]
13. Molecular pharmacology and antitumor activity of palmarumycin-based inhibitors of thioredoxin reductase.
Powis G; Wipf P; Lynch SM; Birmingham A; Kirkpatrick DL
Mol Cancer Ther; 2006 Mar; 5(3):630-6. PubMed ID: 16546977
[TBL] [Abstract][Full Text] [Related]
14. Genistein inversely affects tubulin-binding agent-induced apoptosis in human breast cancer cells.
Liao CH; Pan SL; Guh JH; Teng CM
Biochem Pharmacol; 2004 Jun; 67(11):2031-8. PubMed ID: 15135300
[TBL] [Abstract][Full Text] [Related]
15. [Induction of G2 /M phase arrest and apoptosis of MCF-7 cells by novel benzofuran lignan via suppressing cell cycle proteins].
Yang H; Cai YC; Pang JY; Li YQ; Zeng ZL; Xu ZL; Xian LJ
Yao Xue Xue Bao; 2008 Feb; 43(2):138-44. PubMed ID: 18507339
[TBL] [Abstract][Full Text] [Related]
16. Troglitazone inhibits growth of MCF-7 breast carcinoma cells by targeting G1 cell cycle regulators.
Yin F; Wakino S; Liu Z; Kim S; Hsueh WA; Collins AR; Van Herle AJ; Law RE
Biochem Biophys Res Commun; 2001 Sep; 286(5):916-22. PubMed ID: 11527386
[TBL] [Abstract][Full Text] [Related]
17. Dual G1 and G2/M phase inhibition by SC-alpha alpha delta 9, a combinatorially derived Cdc25 phosphatase inhibitor.
Tamura K; Rice RL; Wipf P; Lazo JS
Oncogene; 1999 Nov; 18(50):6989-96. PubMed ID: 10597298
[TBL] [Abstract][Full Text] [Related]
18. MJ-29 inhibits tubulin polymerization, induces mitotic arrest, and triggers apoptosis via cyclin-dependent kinase 1-mediated Bcl-2 phosphorylation in human leukemia U937 cells.
Yang JS; Hour MJ; Huang WW; Lin KL; Kuo SC; Chung JG
J Pharmacol Exp Ther; 2010 Aug; 334(2):477-88. PubMed ID: 20463006
[TBL] [Abstract][Full Text] [Related]
19. Antagonistic interplay between antimitotic and G1-S arresting agents observed in experimental combination therapy.
Johnson KR; Young KK; Fan W
Clin Cancer Res; 1999 Sep; 5(9):2559-65. PubMed ID: 10499633
[TBL] [Abstract][Full Text] [Related]
20. PTEN tumour suppressor is linked to the cell cycle control through the retinoblastoma protein.
Paramio JM; Navarro M; Segrelles C; Gómez-Casero E; Jorcano JL
Oncogene; 1999 Dec; 18(52):7462-8. PubMed ID: 10602505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
